Title:
5HT2Cレセプター修飾因子
Document Type and Number:
Japanese Patent JP4155926
Kind Code:
B2
Abstract:
The present relation relates to 8-chloro-1-methyl-2,3,4,5-tetrahydro-1 H -3-benzazepine
or a pharmaceutically acceptable salt, solvate, or hydrate thereof for the treatment of a disorder of the central nervous system selected from: depression, atypical depression, a bipolar disorder, an anxiety disorder, an obsessive-compulsive disorder, a social phobia, a panic state, a sleep disorder, sexual dysfunction, psychosis, schizophrenia, migrane or other condition associated with cephalic pain or other pain, raised intracranial pressure, epilepsy, a personality disorder, an age-related behavioral disorder, a behavioral disorder associated with dementia, an organic mental disorder, a mental disorder in childhood, aggressivity, an age-related mental disorder, chronic fatigue syndrome, drug addiction, alcohol addiction, bulimia, anorexia nervosa, or premenstrual tension.
Inventors:
Smith, brian
Smith, jeffrey
Smith, jeffrey
Application Number:
JP2003583332A
Publication Date:
September 24, 2008
Filing Date:
April 11, 2003
Export Citation:
Assignee:
Arena Pharmaceuticals, Incorporated
International Classes:
C07D223/14; A61K31/55; C07D223/16; A61P1/00; A61P3/04; A61P9/00; A61P11/00; A61P13/02; A61P15/00; A61P25/00; A61P25/04; A61P25/06; A61P25/08; A61P25/18; A61P25/20; A61P25/22; A61P25/24; A61P25/28; A61P25/30; A61P25/32; A61P43/00; C07D223/32; C07D403/04; C07D409/04; C07D487/00; C07D491/00; C07D491/04; C07D491/048; C07D513/00
Domestic Patent References:
| JP2502723A |
Foreign References:
| GB1268243A |
Attorney, Agent or Firm:
Hidesaku Yamamoto
Takaaki Yasumura
Natsuki Morishita
Takaaki Yasumura
Natsuki Morishita